Diabetes complications

Factors Associated With Progression From Level 1 to Level 2 Sensor‐Detected Hypoglycaemia in People With Type 1 and Insulin‐Treated Type 2 Diabetes: A Post Hoc Analysis From the Hypo‐ METRICS Study

Diabetes Obes MetabPublished Post hoc analysis of the Hypo-METRICS study

Authors' conclusion

Approximately one sixth of SDH events progressed to L2, with a higher proportion in T1D than T2D. The principal determinants were CV in T1D and mean glucose in T2D. Awareness status was not associated with progression risk during sleep.

Study context

Population
People with T1D and insulin-treated T2D with ≥ 1 hypoglycaemic event in preceding 3 months, wearing blinded CGM and FitBits for 10 weeks23,768 sensor-detected hypoglycaemic (SDH) events
Participants
212 vs 213
Comparison
T1D vs insulin-treated T2D
  • T1Dn = 212
  • T2Dn = 213reference
Primary endpoint
L2 ratio: proportion of sensor-detected hypoglycaemic events progressing to level 2 (L2/(L1 + L2)), and associated variables
Follow-up
10 weeks
Methodological detailsblinded CGM, beta regression, purposeful variable selection
  • Blinded CGM
  • Beta regression
  • Purposeful variable selection

Primary result

As reported in the abstract

L2 ratio

P = 0.03

Further findings

OutcomeOR (95% CI)P value
Predictor of L2 ratio in T1D: CVCV1.07 (1.06–1.09)P < 0.001

Predictor of L2 ratio in T2D: mean sensor glucose

OR (95% CI)P value
T2DMean sensor glucose1.13 (1.08–1.18)P < 0.001

Other candidate predictors

Mean L1-SDH duration, weekly L1-SDH frequency, personal CGM usage and impaired awareness were not principal predictors

Progression to L2 during sleep vs wakefulness

Progression during sleep
21%
Progression during wakefulness
11%
Sleep vs wakefulness P
P < 0.001
L2 ratios during sleep did not differ by awareness status

Original publication

Factors Associated With Progression From Level 1 to Level 2 Sensor‐Detected Hypoglycaemia in People With Type 1 and Insulin‐Treated Type 2 Diabetes: A Post Hoc Analysis From the Hypo‐ METRICS Study. Diabetes Obes Metab. Published 4 August 2026. doi:10.1111/dom.71172

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.